Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Clairmont NS"'
Autor:
Linsky TW; Neoleukin Therapeutics Inc., Seattle, WA, USA., Vergara R; Neoleukin Therapeutics Inc., Seattle, WA, USA., Codina N; Neoleukin Therapeutics Inc., Seattle, WA, USA., Nelson JW; Neoleukin Therapeutics Inc., Seattle, WA, USA., Walker MJ; Neoleukin Therapeutics Inc., Seattle, WA, USA., Su W; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China., Barnes CO; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA., Hsiang TY; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA., Esser-Nobis K; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA., Yu K; Neoleukin Therapeutics Inc., Seattle, WA, USA., Reneer ZB; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA., Hou YJ; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA., Priya T; Neoleukin Therapeutics Inc., Seattle, WA, USA., Mitsumoto M; Neoleukin Therapeutics Inc., Seattle, WA, USA., Pong A; Neoleukin Therapeutics Inc., Seattle, WA, USA., Lau UY; Neoleukin Therapeutics Inc., Seattle, WA, USA., Mason ML; Neoleukin Therapeutics Inc., Seattle, WA, USA., Chen J; Neoleukin Therapeutics Inc., Seattle, WA, USA., Chen A; Neoleukin Therapeutics Inc., Seattle, WA, USA., Berrocal T; Neoleukin Therapeutics Inc., Seattle, WA, USA., Peng H; Neoleukin Therapeutics Inc., Seattle, WA, USA., Clairmont NS; Neoleukin Therapeutics Inc., Seattle, WA, USA., Castellanos J; Neoleukin Therapeutics Inc., Seattle, WA, USA., Lin YR; Neoleukin Therapeutics Inc., Seattle, WA, USA., Josephson-Day A; Neoleukin Therapeutics Inc., Seattle, WA, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Fuller DH; Department of Microbiology, University of Washington, Seattle, WA, USA., Walkey CD; Neoleukin Therapeutics Inc., Seattle, WA, USA., Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.; Department of Infectious Diseases, University of Georgia, Athens, GA, USA., Swanson R; Neoleukin Therapeutics Inc., Seattle, WA, USA., Bjorkman PJ; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA., Gale M Jr; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA., Blancas-Mejia LM; Neoleukin Therapeutics Inc., Seattle, WA, USA., Yen HL; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China., Silva DA; Neoleukin Therapeutics Inc., Seattle, WA, USA. dadriano@neoleukin.com.
Publikováno v:
Science (New York, N.Y.) [Science] 2020 Dec 04; Vol. 370 (6521), pp. 1208-1214. Date of Electronic Publication: 2020 Nov 05.
Autor:
Linsky TW, Vergara R, Codina N, Nelson JW, Walker MJ, Su W, Hsiang TY, Esser-Nobis K, Yu K, Hou YJ, Priya T, Mitsumoto M, Pong A, Lau UY, Mason ML, Chen J, Chen A, Berrocal T, Peng H, Clairmont NS, Castellanos J, Lin YR, Josephson-Day A, Baric R, Walkey CD, Swanson R, Gale M, Blancas-Mejia LM, Yen HL, Silva DA
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2020 Aug 03. Date of Electronic Publication: 2020 Aug 03.